BHB-T cells

Recruiting

18-99 years

All

Phase N/A

20 participants needed

1 Location

Brief description of study

The aim of this study is to biobank blood and stool samples of healthy individuals receiving β-hydroxybutyrate (BHB) supplementation. Additionally, this study will determine whether BHB supplementation increases serum BHB levels and leads to changes in T cell phenotype, including composition (i.e. CD4/CD8), and cytokine secretion. BHB supplementation will be performed through oral administration of HVMN Ketone-IQ, a commercially available BHB supplement, with an active ingredient of R-1,3-Butanediol, which gets converted to BHB.

Detailed description of study

This is a preliminary study to biobank blood and stool samples following oral BHB supplementation in healthy subjects

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research
Age: Between 18 Years - 99 Years
Gender: All

1.1 Inclusion Criteria

· Age of 18 years or older

· Can provide informed consent.

1.2 Exclusion Criteria

Subject is pregnant, a prisoner, or is under 18 years of age.
Subject is actively breastfeeding
History of autoimmune disease
History of inflammatory bowel disease
History of diabetes mellitus and are currently on medical diabetes therapy
History of chronic kidney disease with an eGFR < 60 mL/min/1.73m2
Cancer diagnosis where the subject is receiving active therapy, or cancer history within 5 years (non-melanoma skin cancers are not exclusion criteria)
Use of either a ketogenic diet or intermittent fasting (defined as a fasting period of 16 hours or more per day that is not associated with a medical procedure) during the 4 weeks prior to enrollment.

Updated on 12 Sep 2024. Study ID: 855923

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).